FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine and is a method for the treatment of acute bacterial skin or skin structure infection (ABSSSI) in an adult human subject. The method for the treatment is carried out by injection of an oral loading dose in the form of two doses of 450 mg of 9-[(2,2-dimethyl-propylamino)methyl]minocycline, which are injected in 24 hours or 48 hours, respectively, before the first of the administered oral doses of 300, 450 or 600 mg once a day for 5 or more days. Doses are injected in the form of tablets of 150 mg.
EFFECT: development of an improved method for the treatment of acute bacterial skin or skin structure infection (ABSSSI) in an adult human subject based on oral antibacterial agent – omadacycline.
28 cl, 6 dwg, 30 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHODS FOR TREATMENT AND PREVENTION OF C. DIFFICILE INFECTION | 2017 |
|
RU2751509C1 |
| USING LEVOFLOXACIN IN AEROSOL FORM FOR TREATING MUCOVISCIDOSIS | 2010 |
|
RU2563809C2 |
| ESKETAMINE FOR TREATING DEPRESSION | 2018 |
|
RU2822657C2 |
| PREVENTING HYPOGLYCAEMIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS | 2012 |
|
RU2572703C2 |
| LIXISENATIDE AND METFORMIN FOR TYPE 2 DIABETES TREATMENT | 2012 |
|
RU2623023C2 |
| NOVEL PEPTIDES AND ANALOGS FOR USE IN THE TREATMENT OF ORAL MUCOSITIS | 2014 |
|
RU2668963C2 |
| TREATMENT OF MYOCARDIAL INFARCTION WITH REGENERATED HIGH-DENSITY LIPOPROTEIN | 2017 |
|
RU2798830C2 |
| USE OF COMPOUNDS IN TREATING FUNGAL INFECTIONS | 2021 |
|
RU2805930C1 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING DGLA, AND USE THEREOF | 2015 |
|
RU2714323C2 |
| TREATING DIABETES MELLITUS WITH LONG-ACTING INSULIN FORMULATIONS | 2014 |
|
RU2705797C2 |
